FREE June 11 Webinar on Indigenous Prison-Community Partnership Study

You are invited to watch this webinar, June 11, 2019 (noon to 1 pm, PST) in person or online, presented by Helen Brown, PhD RN, "Work 2 Give: Indigenous and Participatory Knowledge Translation within a Prison-Community Partnership Study" at OR Helen Br

The Week in Review: Jan. 18, 2019 – Jan. 25, 2019

Friday, Jan 25, 2019 News Recap: Using Telemedicine HCV Care Model in Prisons in SPAIN “HCV telemedicine program satisfying, cost-effective in Spanish prison:  A telemedicine program brought high levels of satisfaction and proved cost effective in patients with hepatitis C in a Spanish prison, according to data presented at The Liver Meeting 2018…” Read more about Spain’s prison-based HCV “Telemedicine” treatment model. Saturday in Surrey! Visit HepC

Free CME-certified WEBINARS on Fatty Liver Disease Jan. 29-31, 2019

HepCBC is quite interested in NASH because people with hepatitis C are particularly vulnerable to NASH, even after being cured of hepatitis C!  (Reference for relation between post-SVR HCV and NASH: Register for free CCO webinar: “Identifying and Managing NASH [Non-alcoholic steatohepatitis] in High-Risk Populations: A Silent Epidemic, NASH affects 30 million Americans, or 12% of all adults.  By 202

The Week in Review: March 3, 2017 – March 10, 2017

Friday, March 10, 2017 News Recap Seven Big Events in Six Days! A whirlwind of activity in three far-flung cities for HepCBC: 2 events in Vancouver, 3 in Banff, and 2 in Prince George!! March 1st – We had a busy info booth at Langara College's Nursing Dept. Health Fair, one in which challenges of the current opioid epidemic were featured. March 2nd – Our Vice President and Action Hepatitis Canada Steering Committee Representative, Delvin Gri...

March 6th BCCDC presentation in Prince George, BC

By Cheryl Reitz The March 6th BCCDC presentation in Prince George was a long-awaited experience for HepCBC! Several of us had been very interested when the BC Centre for Disease Control presented its research into the hepatitis C Cascade of Care in BC. Using their agency's huge database, researchers showed that of the 73,320 British Columbians who contracted or were diagnosed with hepatitis C in the 20 years between 1992 and 2012, approximately 25% ...

Strategies to address reimbursement restrictions for Hep C treatment: Lessons from Australia

Event Date: Monday February 6th 3-4:30pm EST Presented by: CATIE, CanHep C and The Kirby Institute Register here In Canada, direct-acting antiviral (DAA) hepatitis C treatments are costly, so provinces and territories limit access to patients based on fibrosis stage and other criteria such as HIV coinfection.  How can we move beyond this approach and achieve a model of access for all? This webinar, taking place February 6th, 3:00 p.m. ET, by...

Knowledge for Change: An Introduction to Access to Generic Hepatitis C Medicines

Check out this new Video from WHA on Access to Generic Hepatitis C Medicines Following the success of the first two webinars in the Knowledge for Change series covering access to diagnostics and medicines, we were pleased to deliver the next in the series, ‘An Introduction to Accessing Generic Hepatitis C Medicines’ on 1 November. The webinar explored the generics landscape for hepatitis C with discussions on legalities, quality and performance of generic

Patient Input Requested for AbbVie 2D-GT4 Combo

HepCBC is seeking individual patient input for our submission to the federal government for the first INTERFERON-FREE drug combo for GENOTYPE 4, AbbVie's "2D-GT4".ADD YOUR VOICE! We will be accepting input from anyone affected by hepatitis C (ALL GENOTYPES, not only Genotype 4) between Friday, Sept. 11 and midnight on Thursday, Sept. 25, 2015 through this confidential online form: PATIENT INPUT FORM for AbbVie 2D-GT4 Free WEBINAR about AbbVie 2D-GT4 availa

SOVALDI (sofosbuvir) WEBINAR July 3, noon (PST) with Dr. Alnoor Ramji: FREE, public invited

HepCBC is co-hosting a FREE Webinar with the Pacific Hepatitis C Network on July 3rd at noon Pacific time. Dr. Alnoor Ramji will present the most accurate and most current information about SOVALDI (sofosbuvir), and will be available to answer your questions. REGISTRATION INFORMATION: Pre-register/Sign-in (anytime before Webinar): Step 1 (at 11:55 am July 3rd): Dial-in (US & Canada): 866-7